myelodysplastic syndrome (mds)

Showing 1 - 25 of 77

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Refine and Assess Readability of Patient, Carer, and Clinician

Completed
  • Myelodysplastic Syndrome (MDS)
  • Carer Treatment Preference Myelodysplasia Questionnaire
  • +2 more
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
Apr 4, 2023

Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Brasschaat, Belgium
  • +9 more
Jan 19, 2023

Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

Completed
  • Acute Myelogenous Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 4, 2023

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Reduced-Intensity Conditioning Regimen
  • Myeloablative Conditioning Regimen
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jan 4, 2023

Myelodysplastic Syndrome (MDS) Trial in United States (MBG453, Azacitidine, Decitabine)

Recruiting
  • Myelodysplastic Syndrome (MDS)
  • Chandler, Arizona
  • +22 more
Dec 5, 2022

Myelodysplastic Syndrome (MDS) Trial in Worldwide (Venetoclax, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Fullerton, California
  • +219 more
Aug 24, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (Lemzoparlimab, Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Birmingham, Alabama
  • +35 more
Aug 19, 2022

Myelodysplastic Syndrome (MDS) Trial in Yamagata (ASTX030)

Recruiting
  • Myelodysplastic Syndrome (MDS)
  • Yamagata, Japan
    Yamagata University Hospital
Jun 20, 2022

Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (S64315 once a week, S64315 twice a week)

Completed
  • Acute Myeloid Leukaemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • S64315 once a week
  • S64315 twice a week
  • New Haven, Connecticut
  • +8 more
May 17, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Tumor (MDS/MPN) Trial in Durham (ADCT-301)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Durham, North Carolina
    Duke University Health System
Jan 10, 2022

Myelodysplastic Syndrome (MDS) Trial in United States (AMV564 14-Day CIV)

Completed
  • Myelodysplastic Syndrome (MDS)
  • AMV564 14-Day CIV
  • Duarte, California
  • +4 more
Oct 11, 2021

Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Recruiting
  • Myelodysplastic Syndrome (MDS)
  • +3 more
  • Cord Blood Transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 22, 2021

Myelodysplastic Syndrome (MDS) Trial (FF-10501-01, Azacitidine)

Withdrawn
  • Myelodysplastic Syndrome (MDS)
  • (no location specified)
Jul 20, 2021

Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI

Completed
  • Myelodysplastic Syndrome (MDS)
  • +2 more
  • WT1:126-134
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021

Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Tampa (PF-04449913)

Completed
  • Myelodysplastic Syndrome (MDS)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 10, 2021

Myelodysplastic Syndrome (MDS) Trial in Cleveland (CPX-351)

Recruiting
  • Myelodysplastic Syndrome (MDS)
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Apr 21, 2021

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Chicago (Haplo-Cord Transplant, Matched Unrelated Donor

Terminated
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Haplo-Cord Transplant
  • Matched Unrelated Donor Transplant
  • Chicago, Illinois
    University of Chicago Cancer Center
Feb 22, 2021

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Infusion of NEXI-001 T Cells)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Infusion of NEXI-001 T Cells
  • Duarte, California
  • +4 more
Feb 16, 2021

Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

Active, not recruiting
  • Hematological Malignancies
  • +6 more
  • NiCord® (omidubicel)
  • Cord Blood Unit
  • Los Angeles, California
  • +51 more
Jan 7, 2021

Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Chemo-sensitive Lymphoma Trial in United States (drug,

Completed
  • Myelodysplastic Syndrome (MDS)
  • +6 more
  • Gainesville, Florida
  • +10 more
Nov 30, 2020

Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS

Recruiting
  • Chronic Myeloid Leukemia (CML)
  • +5 more
  • CliniMACS CD34+ Reagent System
  • +8 more
  • New York, New York
    Columbia University Medical Center
Jun 17, 2020

Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML) Trial in Memphis (device,

Completed
  • Leukemia, Acute Lymphocytic (ALL)
  • +7 more
  • CliniMACS
  • +11 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 3, 2020